Compound Detail
CHEMBL1413199
DIPHENADIONE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL1413199 |
| Name | DIPHENADIONE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | JYGLAHSAISAEAL-UHFFFAOYSA-N |
9
Targets
17
Activities
1
Assay Types
0
PK Parameters
20
Publications
8
Known Names
1
Indications
Molecular Properties
340.4
MW (Da)
4.08
ALogP
3
HBA
0
HBD
51.2
PSA (Ų)
0.67
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Thrombosis
ATC Classification
B01AA10
diphenadione
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: ANTITHROMBOTIC AGENTS
Activity Summary
IC50 17 meas. best 6.28
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 6.28 | 5.7711 | 530.7 | 9 |
| RPMI-8226 CHEMBL614882 | IC50 | 4.9 | 4.9 | 12700.0 | 1 |
| KG-1a CHEMBL4296453 | IC50 | 4.67 | 4.67 | 21300.0 | 1 |
| NCI-H929 CHEMBL4296391 | IC50 | 4.65 | 4.65 | 22200.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.57 | 4.57 | 27200.0 | 1 |
| HL-60 CHEMBL383 | IC50 | 4.55 | 4.55 | 28310.0 | 1 |
| SK-UT-1 CHEMBL2366316 | IC50 | 4.54 | 4.54 | 29200.0 | 1 |
| WI-38 CHEMBL614391 | IC50 | 4.52 | 4.52 | 30100.0 | 1 |
| PBMC CHEMBL613107 | IC50 | 4.49 | 4.49 | 32500.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36345296 | 10.1016/j.cropro.2010.05.009 | Cricetomys gambianus | 9 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Amine oxidase [flavin-containing] A | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Adenosine receptor A3 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prothrombin | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(3) dopamine receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Vascular endothelial growth factor receptor 2 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent serotonin transporter | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent noradrenaline transporter | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Acetylcholinesterase | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Estrogen receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent dopamine transporter | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine